The current pharma business model is unsustainable
World of DTC Marketing
SEPTEMBER 7, 2022
In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. They relied so much on a new drug that they tried to market a product with bad science behind it. More recently developed agents, such as CAR T-cell therapy, may cost almost USD 500,000 annually.
Let's personalize your content